What is the standard dosing of Valtrex (valacyclovir) for herpes labialis (cold sores)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The standard dosing of Valtrex (valacyclovir) for cold sores is 2 grams taken twice daily for one day, with doses separated by about 12 hours. This medication should be started at the earliest sign of a cold sore (tingling, itching, or burning) for maximum effectiveness. For best results, take the first 2-gram dose immediately when symptoms begin and the second 2-gram dose 12 hours later. Valtrex works by preventing the herpes simplex virus from multiplying, which helps reduce the duration and severity of the outbreak. The medication is most effective when taken early in the course of an outbreak, ideally within 24 hours of symptom onset. Common side effects may include headache, nausea, or dizziness. If you experience cold sores frequently (more than 6 outbreaks per year), talk to your healthcare provider about daily suppressive therapy rather than episodic treatment. Patients with kidney problems may require dose adjustment, so inform your doctor about any kidney issues before starting treatment. Some studies suggest alternative dosing regimens, such as valacyclovir 500 mg orally twice a day for 5 days 1, or valacyclovir 1 g orally twice a day for 7-10 days 1, however, the most effective and recommended dosing is 2 grams taken twice daily for one day. It's essential to follow the recommended dosing to ensure maximum efficacy and minimize potential side effects.

From the FDA Drug Label

The recommended dosage of VALTREX for treatment of cold sores is 2 grams twice daily for 1 day taken 12 hours apart. Therapy should be initiated at the earliest symptom of a cold sore (e.g., tingling, itching, or burning). The recommended dosage of VALTREX for the treatment of cold sores in pediatric patients aged greater than or equal to 12 years is 2 grams twice daily for 1 day taken 12 hours apart. Therapy should be initiated at the earliest symptom of a cold sore (e.g., tingling, itching, or burning).

The standard dosing of Valtrex for cold sores is:

  • 2 grams twice daily for 1 day, taken 12 hours apart, for adults and pediatric patients aged 12 years and older. This dosing applies to both adults and pediatric patients aged 12 years and older, and therapy should be initiated at the earliest symptom of a cold sore 2 2.

From the Research

Standard Dosing of Valtrex for Cold Sores

The standard dosing of Valtrex for cold sores is as follows:

  • For episodic treatment, the typical dose is 2 grams every 12 hours for 1 day, taken at the first sign of a cold sore [ 3 ].
  • For chronic suppressive therapy, the typical dose is 1 gram once daily [ 3 ].

Key Considerations

Some key considerations for the dosing of Valtrex for cold sores include:

  • The dose should be taken at the first sign of a cold sore, ideally in the prodromal stage and no later than 48 hours from the onset of lesions [ 3 ].
  • Valacyclovir has greater oral bioavailability and is better absorbed than acyclovir, requiring less frequent dosing [ 4, 5,3 ].
  • Topical antiviral agents can also be used for episodic treatment of cold sores, but are not effective in preventing recurrent episodes [ 3 ].

Comparison with Other Antivirals

Valacyclovir has been compared with other antivirals, such as famciclovir and acyclovir, in terms of efficacy and safety:

  • Valacyclovir appears to be somewhat better than famciclovir for suppression of genital herpes and associated shedding [ 6 ].
  • Valacyclovir has similar efficacy to acyclovir in the episodic and suppressive treatment of genital herpes [ 7 ].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Herpes Labialis: An Update.

Recent patents on inflammation & allergy drug discovery, 2017

Research

Valacyclovir for the treatment of genital herpes.

Expert review of anti-infective therapy, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.